Critical Care / ICU · Ward Pathways · Free — no sign-in
Collapse, pulseless — start the clockwork: quality CPR, adrenaline every 3–5 min, shock the shockable, hunt Hs & Ts, then protect the brain after ROSC.
ABCDE
High-quality CPR 100–120/min, 5–6 cm depth, minimal pauses; adrenaline 1 mg IV q3–5 min; defibrillate VF/pVT at 200 J biphasic; reversible causes in parallel.
CPR quality first:100–120 compressions/min, depth 5–6 cm, full recoil, rotate compressors q2 min, <10 s pauses; waveform capnography (ETCO₂ >10 mmHg = adequate)
Shockable (VF/pVT):shock 200 J biphasic → CPR 2 min → shock; adrenaline 1 mg after initial defibrillation attempts have failed (typically after 2nd–3rd shock), then q3–5 min; amiodarone 300 mg after 3rd shock (or lidocaine 100 mg as alternative)
Non-shockable (PEA/asystole):adrenaline 1 mg IV/IO as early as possible then q3–5 min; no shocks — hunt causes
Reversible causes (Hs & Ts):hypoxia, hypovolaemia, hypo/hyperkalaemia, hypothermia, tension pneumothorax, tamponade, toxins, thrombosis (MI/PE) — treat in parallel, not after
ROSC → 12-lead within minutes:STEMI or high suspicion → cath lab activation even if comatose; no STEMI → CT head/chest as indicated
Post-ROSC bundle:SpO₂ 90–98% (avoid hyperoxia AND hypoxaemia), normocapnia, MAP ≥65, temperature control 32–37.5 °C for comatose survivors maintained ≥36 h (prevent hyperthermia), glucose 8–10 mmol/L, ICU (2025 AHA)
Calculators:
Order set
Adrenaline 1 mg IV/IO q3–5 min
Amiodarone 300 mg (shock-refractory VF/pVT)
Defibrillator pads before arrival if possible
Waveform capnography
ABG + K⁺/glucose during arrest
12-lead ECG immediately post-ROSC
Temperature control 32–37.5 °C (comatose survivors, ≥36 h)
Cath lab activation if STEMI
Monitor
Peri-arrestETCO₂ (fall predicts loss of output; rise predicts ROSC)
Post-ROSC q15 minMAP, SpO₂, ETCO₂-PaCO₂ gradient
ContinuousTemperature probe — prevent fever ≥72 h
≥72 hMultimodal neuroprognostication — never earlier
Escalate / ICU
ETCO₂ <10 after 20 min quality CPR (prognosis grave)
Refractory arrest with reversible cause → E-CPR centre (reasonable, COR 2a — 2025 AHA)
Any ROSC → ICU
Post-ROSC seizures → EEG + treat as status
Criteria
Adrenaline1 mg q3–5 min; early in non-shockable
Amiodarone300 mg after 3rd shock (150 mg after 5th)
Cath labSTEMI (or shock/refractory ventricular arrhythmia/ongoing ischaemia) post-ROSC regardless of coma; not routine for comatose non-STEMI
PrognosticateNot before 72 h, multimodal only
Never
Hyperoxia after ROSC — titrate O₂ down to SpO₂ 90–98%
Vasopressin — no role in cardiac arrest (2025 AHA)
Routine immediate cath for comatose non-STEMI (COACT/TOMAHAWK) — emergent cath only for STEMI/shock/refractory ventricular arrhythmia/ongoing ischaemia
Give routine sodium bicarbonate or calcium
Stop to check pulses mid-cycle for >10 s
Prognosticate in the first 72 h — sedation and TTM confound everything
Key
ETCO₂ is your CPR quality gauge — <10 mmHg means push harder/rotate
Adrenaline + amiodarone (or lidocaine alternative) are the antiarrhythmic/evidence drugs in arrest; vasopressin has no role
Post-ROSC hypotension (SBP <90) doubles mortality — noradrenaline early
Clinical detail — differentials, red flags, pitfalls, disposition
Red flags
Witnessed vs unwitnessed + downtime
ETCO₂ <10 despite quality CPR
Post-ROSC papilloedema/fixed pupils (do not act early)
Recurrent VF — overdrive pacing/ischaemia
Differentials
Acute MI (commonest)
PE — thrombolyse intra-arrest if suspected
Hyperkalaemia (dialysis patient, peaked T)
Toxins: β-blocker, CCB, tricyclic, local anaesthetic (lipid)
Common mistakes
Freon-style interruptions for intubation
Delaying access — IV is first choice (COR 1); IO reasonable if IV unsuccessful/not feasible (COR 2a, 2025 AHA)
Hypoglycaemia missed as cause
Early withdrawal discussions before 72 h
Disposition & follow-up
All ROSC → ICU; coronary angiography if STEMI or unstable; daily sedation holds from 48–72 h for neuro assessment; family communication early and honest.
💊 Treatment detail — doses & preparation
Adrenaline 1 mg (arrest)ACLS
Dose1 mg IV/IO every 3–5 min during arrest
Preparation1 mL of 1:10,000 (0.1 mg/mL) = 1 mg in 10 mL pre-filled syringe; flush 20 mL after
MonitorETCO₂ response; give early in non-shockable rhythms
Amiodarone IVantiarrhythmic
DoseArrest: 300 mg IV/IO bolus (then 150 mg). Stable: 150 mg over 10 min, then 1 mg/min ×6 h, 0.5 mg/min ×18 h
PreparationBolus 300 mg in 20–50 mL D5W; infusion 900 mg in 500 mL D5W (glass/non-PVC)
MonitorQT, LFTs, thyroid; long half-life — interacts with warfarin/digoxin
Noradrenaline (norepinephrine)vasopressor
Dose0.05–1 mcg/kg/min IV infusion, titrate to MAP ≥65
Preparation4 mg in 250 mL D5W or NS (16 mcg/mL) via infusion pump; central line preferred — proximal peripheral vein acceptable short-term
ICU Decoded — original critical-care and internal-medicine pathways by
Dr Javed Akhtar, each cited to a current guideline. For education and quick
reference; verify every dose against local protocols before prescribing.